Tag: landiolol

Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

2 Minute Medicine Rewind April 6, 2020

byAlex Chanand1 others

April 12, 2020

Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

No Result

View All Result

Tag: landiolol

2 Minute Medicine Rewind April 6, 2020

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits